Mylan Launches Generic Lithobid Tablets

Mylan announced the launch of Lithium Carbonate Extended-release Tablets 300mg, the generic version of Noven Therapeutic's Lithobid Tablets.

Lithobid is indicated for the treatment of manic episodes of bipolar disorder and as maintenance treatment for individuals with a diagnosis of bipolar disorder. Lithobid is thought to exert its mood stabilizing effect by replacing sodium to inhibit voltage-sensitive sodium channels, causing stabilization of neuronal membranes.

Lithium Carbonate Extended-release Tablets are available from Mylan in 300mg dosage strength tablets, and are expected to ship immediately.

For more information call (800) RX-MYLAN or visit www.mylan.com.